You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖(02696.HK)與騰訊(00700.HK)、思派健康科技達成戰略合作 打造創新患者管理服務平台
復宏漢霖(02696.HK)宣布,近日公司與騰訊(00700.HK)、思派健康科技在上海簽署戰略合作備忘錄,三方將充分整合各自領域的專長優勢,結合復宏漢霖在生物醫藥領域的豐富經驗和行業洞察,在創新患者管理、互聯網醫療、線上疾病科普等方面展開深度合作,打造覆蓋線上+線下,院內+院外全流程患者管理模式,幫助患者進行規範治療,獲得更好的治療效果,從而延長患者生存週期,提高患者生存品質。復宏漢霖執行董事、首席執行官兼總裁張文傑、騰訊醫療副總裁張猛、思派健康科技執行董事兼總裁李繼分別代表三方出席簽約儀式並簽署了戰略合作備忘錄。 根據戰略合作備忘錄,此次合作將在以下幾個方面展開:一方面利用雲服務、大資料分析、人工智慧技術,在疾病健康教育與服務上開展深入戰略合作,連結優質醫生與醫療資源,構建互聯網醫患模式,說明患者主動性、精細化進行疾病管理,進一步提升公眾對相關疾病的關注度和認知度。另一方面,打造醫生工作與服務平台,致力於促進醫生間開展前沿學術資訊交流,助力醫生提升專業能力,並改善醫患交流、促進患者管理、覆診隨訪全流程線上服務,更高效地觸達、教育與管理患者,提高醫療服務效率,改善患者就醫流程與體驗,促進良好的醫患關係構建。此外,三方還將共同探索與推動企業內部資訊化和數字化平台建設,提升企業的管理與溝通效率,推動企業醫藥創新高品質的發展。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account